A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Summary

This is a randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of evogliptin after oral administration in patients with type 2 diabetes who have inadequate glycemic control on diet and exercise.

Timeline

Start

2013-07

Primary completion

2014-10

Completion

2015-04

Drugs

Indications